Introduction {#s0002}
============

Coronaviruses belong to the family of *Coronaviridae*, a diverse group of envelop-positive-strand RNA virus. In December 2019, a new coronavirus (SARS-CoV2) caused an outbreak in China has shown to cause a number of respiratory and enteric diseases. The illness caused by SARS-CoV2 is known as COVID-19. SARS-CoV2 is highly contagious virus responsible for the global outbreak of a life threatening respiratory illness, intestinal infection, congestive heart and renal failures. According to an estimate of May 21, 2020, more than 5 million cases of COVID-19 have been reported in 200 countries and territories, resulting in more than 323,256 deaths. Efforts such as drug repurposing and vaccine development are underway for the treatment of COVID-19, as such development of effective and targeted inhibitors is exceedingly desirable.

The + ssRNA coronaviruses have genetic material that can function both as a genome and as messenger RNA encode nonstructural protein 5 (Nsp5). The Nsp5 protein has three domains D1, D2 and a unique domain D3. D1 and D2 domain contributes to 3-chymotrypsin like protease activity (3CLpro). 3CLpro of Nsp5 known as Mpro is one of the best characterized drug targets. In SARS-CoV2, the special protease Mpro operates on eleven maturation cleavage sites at the carboxy terminus of the large polyprotein 1ab (Stobart et al., [@CIT0023]). Auto cleavage of Nsp 5 protein results in a mature product with the 3-chymotrypsin like 2 catalytic activity (3CLpro) which further splits to form the eleven non-structural mature products known as Nsp4-Nsp16 proteins (Stobart et al., [@CIT0024]). ORF 1ab gene of SARS-CoV2 encodes a replicase PP1ab. Mpro cleaved products of PP1ab are essential for the transcription and replication of SARS-CoV2 viral RNA (Wu et al., [@CIT0027]). This proteolytic cleavage of PP1ab is crucial for the viral life cycle and is an attractive target for anti-SARS-CoV2 drug discovery.

Mpro molecule comprise of three domains, domain I and II (six-stranded antiparallel β barrels) and domain III (a globular cluster of five helices). Substrate binding site resides in a cleft between domain I and II, while domain III is involved in catalytic function. Dimerization of the protein is required for its catalytic regulation. Glu166 residue is a key amino acid involve in the dimerization of Mpro and creation of substrate binding pocket. Further Cys141 and His41 residue forms a catalytic dyad on the active site of the protein essential for its catalytic function (Anand et al., [@CIT0001]). Recently studies have been reported on targeting SARS-CoV-2 Mpro protein using computer based drug designing approach (Das et al., [@CIT0007]; Islam et al., [@CIT0013]; Mittal et al., [@CIT0018]; Umesh et al., [@CIT0026]).

High-throughput *in silico* based screening of compounds against biological targets has recently gained much attention. As such, *in silico* screening tools have gained considerable importance in meeting the special challenges of antiviral drug discovery. In this process, natural or synthetic compound libraries are filtered by different screening methods such as docking and ligand-based similar searches, computer-aided prediction of properties limiting to a smaller set of promising candidates for their biologic testing. This rational approach makes the drug discovery process highly efficient, goal-oriented and cost-effective. Screening of natural compound libraries have led to few lead molecules which are safe drug candidates against several diseases. In the present study, we screened a small library of 267 phytochemicals from *Curcuma longa* L. (Zingiberaceae family) against Mpro protein inhibition.

Materials and methods {#s0003}
=====================

Curcuma longa phytochemical retrieval and preparation {#s0004}
-----------------------------------------------------

A total of 267 compounds present in *Curcuma longa* were obtained from the various literature and search engine platforms such as PubMed, Google Scholar, Web of Science, Science Direct, Scopus, Semantic Scholar, Medline and PubMed Central (Lu, [@CIT0017]). The structures of phytochemicals were prepared using Marvin Sketch software (<https://chemaxon.com/products/marvin>). The 3 D or 2 D structures of other reference compounds against targeted protein was retrieved from the NCBI PubChem in .sdf format (Xie, [@CIT0028]). Open label molecule format converter (O'Boyle et al., 2011) performed conversion of 2 D to 3 D conformation, conversion from .sdf to .mol file. Ligands energy was minimized by applying mmff94 force field and conjugate gradients optimization algorithm using PyRx-Python prescription 0.8 for 200 steps (Chitrala & Yeguvapalli, [@CIT0004]).

Protein retrieval and preparation {#s0005}
---------------------------------

Three dimensional structure of SARS-CoV2 main protease (Mpro, 3CLpro) (PDB ID: 5RFS) protein was obtained from Protein Data Bank (<https://www.rcsb.org/>) (Berman et al., [@CIT0003]). The resolution of the retrieved structure was 1.70 Å. The 3 D structure of Mpro protein was loaded into UCSF Chimera for molecular docking preparation (Pettersen et al., [@CIT0021]). Protein model was cleaned and optimized by removing the ligands as well other heteroatoms including water. After that energy minimization of protein structures was performed by steepest descent method has 100 steps (step size 0.02 Å), and conjugate gradient method has ten steps (step size0.02 Å) by using UCSF Chimera.

Molecular docking studies {#s0006}
-------------------------

For docking experiments, the protein and the ligands were loaded into Auto Dock Tools 1.5.6 (ADT) (Trott & Olson, [@CIT0025]). Gestgeiger partial charges assigned after merging non polar hydrogen and torsions applied to the ligands by rotating all rotatable bonds. Docking calculations were performed on the protein model. Polar hydrogen atoms, Kollman charges, and solvation parameters were added with the aid of Auto Dock tools. Auto Dock 4.2 offers the option of three search algorithms to explore the space of active binding with different efficacy. We used the Lamarckian Genetic Algorithm in this study. The grid box includes the entire binding site of the particular proteins and provides enough space for the ligands translational and rotational walk. For each of the 30 independent runs, a maximum number of 27,000 GA operations generated on a single population of 150 individuals. Operator weights for the rate of crossover, rate of gene mutation, and elitism was defaulting parameters (0.80, 0.02, and 1, respectively). Thereafter, LigPlot+ (v.1.4.5) and UCSF Chimera (v.1.10.2) used for visualization of the interaction pattern in the protein-ligand complex (Laskowski & Swindells, [@CIT0016]).

MM-GBSA analysis {#s0007}
----------------

Prime MM-GBSA (Molecular Mechanics/Generalized Born Model and Solvent Accessibility) was used to evaluate the protein and protein-ligand binding energies, which includes the VSGB solvent model, OPLS_2005 force field, and rotamer search algorithms. The Prime MM-GBSA simulation was performed by using the Glide pose viewer file to compute the total free energy of binding. The MM/GBSA calculations were attained to evaluate the relative binding affinity of protein and protein-ligand complex (reported in kcal/mol). As the MM/GBSA binding energies are approximate free energies of binding, a more negative value indicates stronger binding (Kalirajan et al., [@CIT0015]).

Prediction of inhibitory concentration {#s0008}
--------------------------------------

The prediction of IC50 concentration of lead compounds were performed having binding affinity below --6.00 kcal/mol. Standard inhibitors IC50 including shikonin (15.75 µM), tideglusib (1.55 µM), carmofur (1.82 µM), PX-12 (21.39 µM) and disulfiram (9.35 µM) were retrieved from *in vitro* experiments performed elsewhere (Jin et al., [@CIT0014]). Linear regression analysis was performed through GraphPad Prism software to generate the pIC50.

Molecular dynamics simulation {#s0009}
-----------------------------

Lead *Curcuma longa* compounds as predictors of Mpro protease inhibitor of SARS CoV2 were identified from docking study subjected to molecular dynamics simulation and evaluate their conformational space and inhibitory potential. Molecular dynamics simulation was performed using GROningen MAchine for Chemical Simulations (GROMACS) version 5.1.1. Protein parameters were generated using gromos43a1 force field. Ligand parameters for same force field were generated using PRODRG server (Schüttelkopf & van Aalten, [@CIT0022]). Gmxeditconf tool was used to generate dodecahedron simulation box. Solvation was performed with SPC water model using gmx solvate tool. Gmxgenion tool was utilized to electro-neutralize the system. Following neutralization, energy minimization was performed to remove steric clashes and optimize of structure. After energy minimization, system was equilibrated in two steps. In first step of 100 picoseconds of NVT equilibration, system was heated up to 300 K to stabilize the temperature of the system. In second step of 100 picoseconds of NPT ensemble, pressure and density of system was stabilized. Barostat was maintained using Parrinello-Rahman barostat (Parrinello & Rahman, [@CIT0020]). Bonds length were kept conserved using linear constraint solver (LINCS) algorithm (Hess et al., [@CIT0011]). Long range interaction were handled using particle mesh Ewald (PME) summation method (Darden et al., [@CIT0006]). This well equilibrated system with desired temperature and pressure was used to compute trajectory of 30 nanoseconds on a Linux machine with Intel core i-7 processor (32 GB RAM).

Trajectory analysis and protein-ligand interaction energy analysis {#s0010}
------------------------------------------------------------------

Trajectory analysis was performed using various GROMACS analysis tools. The root mean square deviation (RMSD) and root mean square fluctuations (RMSF) of protein were calculated using gmx rms, and gmxrmsf tools respectively. Solvent accessible surface area and radius of gyration were computed by gmxsasa and gmx gyrate tools respectively. Various energy related parameters were estimated using gmx energy tool. Secondary structure estimation was done by gmxdodssp tool. Hydrogen bonds were analyzed using gmxhbond tool. VMD (Humphrey et al., [@CIT0012]) and PyMol (DeLano, [@CIT0009]) was used for the visualization and plots were prepared using Grace Software.

Quantification of interaction energy between lopinavir, C**1** and C**2** was performed by calculating strength of the interaction between ligands and protease active site amino acid residue; it is also useful to estimate the non-bonded interaction energy between target protein and ligand. Tools like gmx grompp and gmx energy were used to calculate the interaction energy between the target protein and ligand. Interaction energy between two interacting species constitutes two interactions, interactions between charged components and non-charged charged components called as Coulombic short range (SR) interactions and Lennard-Jones-SR interaction energies.

Principal component analysis and free energy landscape {#s0011}
------------------------------------------------------

Principal component analysis (PCA) is a widely used analytical technique to illustrate the slow and functional motions for bio-molecules (Bahar et al., [@CIT0002]). The principal components of the protein were obtained by diagonalizing and solving the eigenvalue and eigenvectors for the covariance matrix. The eigenvectors are a representation of the direction of the motion whereas eigenvalues represent the magnitude of motion along with the direction. The covariance matrix for illustration of PCA was calculated using GROMACS analysis tool gmx cover. gmx cover builds and also diagonalizes the covariance matrix. Another GROMACS analysis tool gmxanaeig was utilized to calculate the overlap between principal components and coordinates of the trajectory.

Free energy landscape (FEL) is a representation of possible conformations taken by a protein in molecular dynamics simulation along with the Gibbs free energy. FEL represents two variables that reflect specific properties of the system and measure conformational variability. FEL was calculated using probability distribution from the essential plane composed of first two eigenvectors. gmx sham tool was used for construction of FEL.

Results and discussion {#s0012}
======================

Docking screening of 267 *Curcuma longa* phytochemicals against Mpro protein revealed six lead compounds exhibiting better binding potential than standard/reference compounds. These phytochemicals showed tight binding energy ranging from --9.08 to --7.04 kcal/mole to Mpro protein, compared to the standard inhibitors *viz*. shikonin, lopinavir, alpha ketomide, tideglusib, 1,3-Bis(p-anilinophenoxy)-2-propanol (N3), carmofur, 2-(Secbutyldisulfanyl)-1h-imidazole (PX-12), and disulfiram ranging from --5.41 to --2.55 kcal/mole ([Figure 1(A)](#F0001){ref-type="fig"}). The nomenclature, structure, and molecular weight of these six compounds (cutoff less than --5.00 kcal/mole binding energy) are described in the [Supplementary Table 1](https://doi.org/10.1080/07391102.2020.1776157). Compound **C1** (1E,6E)-1,2,6,7-tetrahydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione) and **C2** (4Z,6E)‐1,5‐dihydroxy‐1,7‐bis(4‐hydroxyphenyl)hepta‐4,6‐dien‐3‐one showed minimum binding score of --9.08 and --8.07 kcal/mole against Mpro protein, compared to shikonin (--5.41 kcal/mole) a standard Mpro inhibitor. Type of amino acid residue involved in the protein-ligand interaction such as hydrogen bonding, and hydrophobic interaction are summarized in [Supplementary Table 2](https://doi.org/10.1080/07391102.2020.1776157). In addition, on the basis of reported 50% inhibitory concentration (IC50) of standard/reference compounds against Mpro protein, we attempted to predict the IC50 of the lead phytochemicals. The predicted IC50 values for the lead compounds were in the range of 40.6 to 24.4 µM which were comparatively higher from the IC50 of standard compounds that range between 15.7 to 21.3 µM ([Figure 1(B)](#F0001){ref-type="fig"}). A relatively weak positive correlation (R2 = 0.2761) was noted among the binding energy and pIC50 of the test compounds ([Figure 1(B)](#F0001){ref-type="fig"}). MM-GBSA analysis of the lead (C**1** and C**2**) and standard inhibitor (lopinavir) bound Mpro protein and unbound protein was performed and the results are shown in [Supplementary Table 3](https://doi.org/10.1080/07391102.2020.1776157). Free energy of unbound protein; lead inhibitor, C**1**, and C**2** bound Mpro protein complex was --12755.75, --2831.23, --12663.69, and --12903.46 respectively in MM-GBSA analysis.

![Docking score of lead *Curcuma longa* phytochemicals against SARS-CoV2 main protease M^pro^ and predicted IC~50~ concentration. (A) Docking score of lead phytochemicals (--7.04 kcal/mol ≤) against SARS-CoV2 main protease M^pro^. (B) Predicted IC~50~ concentrations of the lead molecules. (C) and (D) Structure of lead *Curcuma longa* phytochemicals C**1** (1E,6E)-1,2,6,7-tetrahydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione) and C**2** (4Z,6E)‐1,5‐dihydroxy‐1,7‐bis(4‐hydroxyphenyl)hepta‐4,6‐dien‐3‐one. Abbreviations: a = Shikonin; b = Lopinavir; c = Alpha ketomide; d = Tideglusib; *e* = 1,3-Bis(p-anilinophenoxy)-2-propanol (N3); f = Carmofur; *g* = 2-(Secbutyldisulfanyl)-1h-imidazole (PX-12); h = Disulfiram.](TBSD_A_1776157_F0001_C){#F0001}

Next we determined the surface structure of two lead phytochemicals (C**1** and C**2**), their binding with Mpro protein and the type of interaction of amino acid residues. The binding pocket of Mpro protein docked with the standard inhibitor, lopinavir and compounds C**1** and C**2** are shown in docking pose ([Figure 2(A)](#F0002){ref-type="fig"}). Amino acid Thr190, Thr25, and Glu166 residues were involved in hydrogen bonding with compounds C**1** and C**2**. Glu166 interacted with O5, Thr190 and Thr25 interacted with O1 and O2 of the C**1** and C**2** with 3.02, 3.01 and 2.91 Å bond length. Thr45, Cys44, Ser46, Cys145, Pro168 and Met165 amino acid residues interacted with the Mpro protein by hydrophobic interaction ([Figure 2](#F0002){ref-type="fig"}). Importantly, C**1** and C**2** utilized virtually all amino acid residues (Thr45, Cys44, Met165, Glu166, Cys145, and Ser46) in their interaction with the Mpro protein, compared to the standard inhibitors and Mpro protein interaction ([Supplementary Table 2](https://doi.org/10.1080/07391102.2020.1776157)). Compounds C**1** and C**2** showed interaction with amino acids Glu166, Cys145, and Pro168 whose involvement is recently reported with compound13b-Mpro interaction (Zhang et al., [@CIT0029]). Compound C**1** demonstrated unique interaction with Pro168 and Thr190 residue in comparison to lopinavir that might be responsible for its minimum binding energy against Mpro protein.

![*Curcuma longa* lead phytochemical interaction with SARS-CoV2 M^pro^ protein. (A) Surface structure of M^pro^ protein interacted with lead compound C**1 (**1E,6E)-1,2,6,7-tetrahydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione). Green color represents the mentioned amino acid involved in hydrogen bonding. (B) Ligplot representation of lead compound C**1** and Mpro protein (C) *Curcuma longa* lead phytochemical C**2** (4Z,6E)‐1,5‐dihydroxy‐1,7‐bis(4‐hydroxyphenyl)hepta‐4,6‐dien‐3‐one) bound with SARS-CoV2 main protease M^pro^. Green color represents the mentioned amino acid involved in hydrogen bonding. (D) Ligplot representation of compound C**2** and M^pro^ protein. (E) Surface structure with superimposed *Curcuma longa* phytochemicals C**1** (red color) and C**2** (magenta color) and standard inhibitor lopinavir (cyan color). (F) Ligplot representation of standard inhibitor lopinavir with SARS-CoV2 main protease M^pro^.](TBSD_A_1776157_F0002_C){#F0002}

The enzyme SARS-CoV-2 Mpro along with other proteases is involved in the generation of various nonstructural proteins by cleaving the polyproteins (translated from viral RNA) at specific sites. It has been reported that Cys-His dyad along with Ala, Gly, Gln, Leu and Ser amino acid residues marks the Mpro cleavage site (Zhang et al., [@CIT0029]). Similarly, our *in silico* docking studies revealed that phytochemicals C**1** and C**2** binds with Ser46 and Cys44 residues which might disrupt the Cys-His dyad formation crucial for Mpro protease activity. Compound 1, 2, 6, and 7 formed hydrogen bond with Mpro amino acid residues His41, Glu166, Cys44, Thr25 Thr26 and Thr190 using oxygen atoms on carbon 3, 7, and 18; carbon 3, 7, 18; carbon 3 and 18; and carbon 3, 7, 18, respectively. Oxygen atom at C12 and C14 of compound 4 and 7; and at C10 and 18 of compound 8 were involved in hydrogen bonding with Asn119 and Asn142 amino acid residues. Other lead compounds 3, 4, 5, and 6 showed better tight binding to Mpro active site in comparison to standard inhibitors ([Figure 1(A)](#F0001){ref-type="fig"}). Besides hydrogen bond interaction, compound 3, 4, 5, 6 and 7 showed hydrophobic interaction with His41 and Met49 ([Supplementary Table 2](https://doi.org/10.1080/07391102.2020.1776157)). Zhang et al. ([@CIT0029]) showed the involvement of His41 catalytic and Met49 other than catalytic site residues in the interaction with potential Mpro inhibitor site (Zhang et al., [@CIT0029]). Our results indicate that the oxygen atoms in the lead structure play an important role in Mpro active site binding and stabilizing the complex through hydrogen bond interaction. Moreover we also superimposed the Mpro free and Mpro ligand bound protein structure to determine the effect of ligand binding on the 3 D conformational change in the protein structure. Minor deviation in RMSD value (0.341 Å) among the superimposed structure showed that the ligand binding did not affect the overall 3 D structure of the protein ([Figure 3(B)](#F0003){ref-type="fig"}).

![Plot of molecular dynamic simulation trajectories of COVID-19 M^pro^ protein and protein-ligand complex during 30 ns simulation. (A) The root mean square deviation (RMSD) of solvated SARS-CoV2 M^pro^ protein backbone and in complex with *Curcuma longa* compounds C**1**, C**2** and standard protease inhibitor lopinavir during 30 ns molecular dynamics simulation. (B) The root mean square deviation (RMSD) of solvated SARS-CoV2 M^pro^ whole protein and in complex with compounds C**1**, C**2** and lopinavir during 30 ns molecular dynamics simulation. (C) The root mean square fluctuation (RMSF) values of solvated SARS-CoV2 M^pro^ protein and in complex with compounds C**1**, C**2** and lopinavir plotted against residue numbers. (D) Plot of radius of gyration (Rg) during 30 ns molecular dynamics simulation of SARS-CoV2 M^pro^ protein and in complex with compounds C**1**, C**2** and lopinavir. Unbound protein parameters are depicted in black color. Protein-ligand complex C**1**, C**2** parameters are shown in green and blue color respectively. Protein-lopinavir complex is shown in red color.](TBSD_A_1776157_F0003_C){#F0003}

We utilized the X-ray crystal structure of recently published COVID-19 Mpro protein (PDB ID: XYZ) to dock the *Curcuma longa* phytochemicals and the standard inhibitor lopinavir. These virtual structures were subjected to 30 ns MD simulations to study the comparative conformation dynamics of the unbound and bound ligand forms. Energy, temperature, pressure and density of the unbound protein of compounds C**1**, C**2** and standard inhibitor lopinavir were stabilized during the 30 ns simulation ([Supplementary Figure 1](https://doi.org/10.1080/07391102.2020.1776157)). Further potential energy of the protein and protein ligand complexes are provided in [Supplementary Figure 2](https://doi.org/10.1080/07391102.2020.1776157). Root-mean-square deviation (RMSD) analysis computes the average distance between the atoms of test protein during simulation. The analysis provides insights into protein conformation, stability and equilibrium of the system during simulation (Gohlke et al., [@CIT0010]).The average backbone RMSD for unbound and compounds C**1**, C**2** and standard lopinavir bound Mpro protein were found to vary between 0.23 to 0.27 nm and remained stable throughout the entire MD simulation period ([Figure 3(A,B)](#F0003){ref-type="fig"}). Unbound and compound C**1** bound Mpro protein backbone simulation was stable for last 6 ns of the simulation ([Figure 3(A)](#F0003){ref-type="fig"}). It should be noted that compound C**2** and Mpro protein complex backbone showed stable RMSD (between 0.2 and 0.25 Å) till the termination of the simulation ([Figure 3(A)](#F0003){ref-type="fig"}). The whole protein and protein-ligand complex RMSD showed comparative more stability than the protein backbone RMSD during 30 ns simulation. RMSD of compound C**2** bound Mpro protein complex was more stable (≈0.3 Å) than M^pro^-lopinavir complex throughout the 30 ns simulation ([Figure 3(B)](#F0003){ref-type="fig"}). These results endorsed that simulations are perfect for further computational analysis.

Next we analyzed the effect of *Curcuma longa* phytochemicals compound C**1** and C**2** binding on internal dynamics in comparison to lopinavir binding by calculating the root mean square fluctuation (RMSF) of the Cα atoms ([Figure 3](#F0003){ref-type="fig"}). Average RMSF value for protein, protein-lead compound C**1** and C**2** were 0.20, 0.21, and 0.20 nm respectively. Result showed that binding of C**1** and C**2** to Mpro protein mostly decreased the RMSF values. It should be noted that compound C**1** and C**2** binding generated substantial decrease of RMSF values in some regions which involve residue 40--55 and 80--115 ([Figure 3(C)](#F0003){ref-type="fig"}). Moreover the result showed that the binding of compound C**2** did not exhibit fluctuation at 150--200 amino acid residues in comparison to unbound protein. Amino acid residue of this region plays an important role in binding of the standard inhibitor and phytochemicals from *Curcuma longa* ([Supplementary Table 2](https://doi.org/10.1080/07391102.2020.1776157)). These results indicate that the key amino acid residues in 40--55; 80--115; and 150--200 regions may generate strong interaction with the phytochemicals.

Radius of gyration (Rg) is a parameter to assess the folding of regular secondary structures into 3-dimensional protein structure. Rg indicates change in protein structure compactness and its overall dimension. The effect of compounds C**1** and C**2** binding on Rg value of the protein was computed and compared with lopinavir binding to M^pro^ ([Figure 3(D)](#F0003){ref-type="fig"}). Binding of C**1** and C**2** initially (≈5--10 ns) decreased the Rg value, however, after that up to 30 ns the values was relatively in the range of 2.1 to 2.15 nm for both unbound and ligand bound protein. Average Rg value for unbound protein, protein-lead compound C**1** and C**2** were 2.14, 2.12 and 2.13, respectively during 30 ns simulation. Secondary structures in the unbound protein were not much affected due to the binding of these compounds to the Mpro protein during the 30 ns simulation ([Supplementary Figure 3](https://doi.org/10.1080/07391102.2020.1776157)). The result suggested tight packing of the protein after ligand binding thus making a stable complex.

Non bonded interaction involved in lead compound (C**1** and C**2**) and lopinavir bound M^pro^ protein active site was computed in terms of short range (SR) Coulomb and Lennard-Jones energies during 30 ns MD simulation ([Figure 4(A--C)](#F0004){ref-type="fig"}). The total interaction energy of protein-ligand complex was also calculated. The average Coulomb-SR energy for *C. longa* lead phytochemical C**1,** C**2** and lopinavir interacting with amino acid at active site of M^pro^ protein was --87.0000 ± 15, --85.1703 ± 6.7, and --51.266 ± 12 kJ/mole respectively. The average Lennard-Jones-SR energy for C**1,** C**2** and lopinavir interacting with the M^pro^ amino acid residue was --130.396 ± 9.7, --166.697 ± 4.5, and --130.529 ± 15 kJ/mole respectively. The result showed that lead C**2-**M^pro^ interaction at active site possesses significantly lower Lennard-Jones-SR energy than lopinavir. Moreover, the total interaction energy of C**2-**M^pro^ interaction (--251.8673 ± 5.6 kJ/mole) at active was significantly lower than, C**1-**M^pro^, and lopinavir**-**M^pro^ interactions (--217.396 ± 12.35 and --181.795 ± 13.5 kJ/mole respectively). Over all, the result showed that due to significantly lower total interaction energy, C**2** might act as potent Mpro inhibitor in comparison to lopinavir.

![Short range energy evaluation between the protein and the hit molecules. (A) The short range Coulombic and Lennard-Jones interaction energy of C**1** interacting with amino acid residue at M^pro^ active site. (B) The short range Coulombic and Lennard-Jones interaction energy of C**2** interacting with amino acid residue at M^pro^ active site. (C) The short range Coulombic and Lennard-Jones interaction energy of lopinavir interacting with amino acid residue at M^pro^ active site. Coulombic and Lennard-Jones short range (SR) interaction energy are shown in orange and green color.](TBSD_A_1776157_F0004_C){#F0004}

Solvent accessibility surface area (SASA) determines the bimolecular surface area assessable to surrounding solvent molecules. The change in SASA for unbound protein and protein-lead compound C**1** and C**2** complex were analyzed and compared with protein-lopinavir complex ([Figure 5(A)](#F0005){ref-type="fig"}). A significant change in SASA was observed due to binding of C**1** and C**2** at the active site of the protein. Average SASA value of unbound protein and protein-lead compound C**1** and C**2** complex during the 30 ns simulation were 135, 133, and 137 nm2, respectively. Hydrogen bond formation plays an important role in the stabilization of protein and protein--ligand complex structures by minimizing the energy of the system. Intra molecular, protein-water and protein-ligand hydrogen bonding pattern were studied in unbound and ligand bound Mpro protein ([Figure 5(B,C)](#F0005){ref-type="fig"}). Average value of intra molecular and protein-water hydrogen bonding in unbound protein C**1** and C**2** bound protein complex were 215, 214 and 211; and 489, 483 and 486 during simulation. Moreover the average H-bonding in protein-lead compound 1 and 2 complex was 3.11 and 3.51 during the 30 ns simulation ([Figure 5(D)](#F0005){ref-type="fig"}). Overall, the H-bonding pattern in protein-lead compound C**1** and C**2** interaction showed the energetically favorable and stable complex formation.

![Plot of solvent accessible surface (SASA) region and hydrogen bond formation during 30 ns MD simulation. (A) Plot of solvent accessible surface area (SASA) during 30 ns molecular dynamics simulation of SARS-CoV2 M^pro^ protein and in complex with *Curcuma longa* compounds C**1**, C**2** and standard protease inhibitor lopinavir. (B) Plot of number of hydrogen bond formation with in the SARS-CoV2 M^pro^ protein, SARS-CoV2 Mpro protein complex with compound C**1**, C**2** and lopinavir. (C) Plot of number of hydrogen bond formation between water and SARS-CoV2 M^pro^ protein, SARS-CoV2 M^pro^ protein complex with compound C**1**, C**2** and lopinavir. (D) Plot of number of hydrogen bond formation between SARS-CoV2 M^pro^ protein and compound C**1**, C**2** and lopinavir. Unbound protein parameters are depicted in black color. Protein-ligand complex C**1** and C**2** parameters are shown in green and blue color. Protein-lopinavir complex is shown in red color.](TBSD_A_1776157_F0005_C){#F0005}

Next we studied the collective motion of the unbound and bound compounds C**1** and C**2** with Mpro protein from the molecular dynamics trajectories using principal component analysis (PCA). The analysis is based on the strenuous motion of Cα atom of the protein through eigenvectors (overall direction of motion of the atoms) and eigenvalues (atomic contribution of motion) (David & Jacobs, [@CIT0008]). MD trajectories of unbound, lead compound as well as lopinavir bound protein were examined with the PC for better understanding of the structural and conformational changes in Mpro protein due to ligand binding. PCA analysis indicated that lead compound **2** bound Mpro protein complex depicted lesser collective motion of the protein in comparison to unbound and lead compound 1 bound protein ([Figure 6(A--D)](#F0006){ref-type="fig"}). As a result of lesser flexibility, conformational space covered by lead 2-protein complex was narrower than he unbound protein. These results conclude that compound C**2** bound Mpro protein was more stable than the unbound and lopinavir bound protein.

![Projection of protein atoms in phase space along the first two principal eigenvectors. (A) COVID-19 M^pro^ protein (B) COVID-19 M^pro^ protein complexed with standard protease inhibitor lopinavir. (C) COVID-19 M^pro^ protein complexed with *Curcuma longa* compound C**1**. (D) COVID-19 M^pro^ protein complexed with *Curcuma longa* compound C**2**. (E) Superimposed plot showing COVID-19 M^pro^ unbound protein and protein complexed with compound C**1**, C**2** and lopinavir.](TBSD_A_1776157_F0006_C){#F0006}

To visualize the energy minima landscape of unbound, C**1**, C**2** and lopinavir bound Mpro protein, we studied the free energy landscape (FEL) against first two principal components PC1 (radius of gyration-Rg) and PC2 (root-mean-square deviation-RMSD) which revealed ΔG value 0 to 10 kJ/mol ([Figure 7(A--C)](#F0007){ref-type="fig"}). The shape and size of the minimal energy area (shown in blue) indicate the stability of the protein and protein-lead compound complex. Smaller and more centralized blue areas suggest the stability of the protein and their corresponding complex. [Figure 7](#F0007){ref-type="fig"} indicates that compound C**2** is more stable than unbound protein as well as lead compound C**1** and lopinavir bound Mpro protein. Thus these compounds have the potential to induce Mpro protein to enter the local energy minimal state.

![Free energy landscape of the first two principal components for (A) COVID-19 M^pro^ protein. (B) COVID-19 M^pro^ protein-C**1** complex. (C) COVID-19 M^pro^ protein-C**2** complex. (D) COVID-19 M^pro^ protein-lopinavir complex.](TBSD_A_1776157_F0007_C){#F0007}

The predictions on drug-likeness and toxicity were performed. Compound C**1** is predicted as not absorbed and not brain penetrant as it located outside the Egg (white circle) whereas compound C**2** and lopinavir were predicted as well-absorbed based on their position inside the Egg ([Figure 8(A--D)](#F0008){ref-type="fig"}). The lead compound C**2** exhibited inaccessibility (out of Egg yolk) to blood brain barrier. It is noteworthy that compound C**2** showed high probability of passive absorption by the gastrointestinal tract. Our results further showed that standard inhibitor lopinavir is predicted to be actively effluxed by P-glycoprotein (blue dot) while compound C**1** and C**2** are predicted as non-substrate of P-gp (red dot) (Daina et al., [@CIT0005]). Bioavailability radar analysis showed that lopinavir and C1 are too flexible and polar predicting that these compounds may not be orally bioavailable. Compound C**2** in contrast, showed flexibility and polarity in the optimal region (pink color) of drug-likeness ([Figure 8(D)](#F0008){ref-type="fig"}).

![Boiled egg diagram and bioavailability radar map of *Curcuma longa* compounds C**1**, C**2** and standard protease inhibitor lopinavir. (A) Boiled egg diagram of lopinavir and compound C**1** and C**2.** Bioavailability radar map of (B) Lopinavir (C) compound C**1** and (D) compound C**2** depicting the LIPO (lipophilicity), SIZE (molecular weight), POLAR (polarity), INSOLU (insolubility) INSATU (insaturation) and FLEX (rotatable bond flexibility) parameters.](TBSD_A_1776157_F0008_C){#F0008}

Physiochemical properties such as fraction Csp3 (FCsp3), H-bond acceptor count (NH-BA), H-bond donor count (NH-BD), molar refractivity (MR), molecular weight (MW), number of heavy atoms (NHA), number of aromatic heavy atoms (NAHA) and topological polar surface area (TPSA) of lopinavir and compounds C**1** and C**2** are depicted in [Figure 9(A](#F0009){ref-type="fig"},B). Compound C**1** and C**2** possess most of the physiochemical properties in the range of drug-likeness properties. Toxicological profile of lopinavir and C**1** and C**2** are shown in [Figure 9(C)](#F0009){ref-type="fig"}. The predicted LD50 of compound C**2** was less than half of the standard inhibitor. Hepatotoxicity, carcinogenicity, immunotoxicity, mutagenicity and cytotoxicity prediction depicted inactive scores for all the test compounds. It should be noted that all test compounds were designated to the category of toxicity class ([Figure 9(C)](#F0009){ref-type="fig"}). Overall toxicity prediction showed C**2** to possess low toxicity profile than compound C**1**.

![Physiochemical properties and toxicological parameters of COVID-19 M^pro^ standard inhibitor lopinavir, compounds C**1** and C**2**. (A) F-Csp3, NH-BA, NH-BD and MR physiochemical parameters of standard and compounds C**1** and C**2**. (B) MW, NHA, NAHA, and TPSA physiochemical parameters of standard and compounds C**1** and C**2**. (C) Toxicological profile of standard and C**1** and C**2** compounds. F-Csp3, Fraction of sp3 carbon; NH-BA, Number of hydrogen bond acceptor; NH-BD, Number of hydrogen bond donor; MR, Molar refractivity; MW, Molecular weight; NHA, Number of heavy atoms; NAHA, Number of aromatic heavy atoms; and TPSA, Topological polar surface area; PLD~50~, Predicted LD~50~ \[mg/kg body weight\]; PTC, Predicted toxicity class; HP, Hepatotoxicity Probability; CP, Carcinogenicity Probability; IP, Immunotoxicity Probability; MP, Mutagenicity Probability; CP', Cytotoxicity Probability; IA, Inactive.](TBSD_A_1776157_F0009_C){#F0009}

Conclusions {#s0013}
===========

The present investigation identified some lead compounds obtained from *Curcuma longa* in the inhibition of COVID-19 Mpro. Molecular docking study confirmed the binding potential of compounds C1 and C2 at the active site of the enzyme. The 30 ns simulation revealed that the protein-lead compound complex possess stable conformation and lower protein-ligand interaction energy. Compound C2 exhibited decent oral bioavailability and lower predicted LD50 value than the standard Mpro inhibitor lopinavir in computational investigation. Other physiochemical and toxicological property prediction of the compound C1 and C2 necessitates further *in vitro* and *in vivo* validation of COVID-19 antiviral activity. Approximately five *Curcuma longa* compounds showed tight binding at Mpro active site demonstrating the presence of more than one inhibitor in a single natural product indicates its potential against COVID-19 virulence. Overall, the study concludes that *Curcuma longa* possess COVID-19 Mpro inhibitory potential for further testing and development as therapeutics against human coronavirus.
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